Protagonist Therapeutics Inc - PTGX - stock price prediction, stock price target, analyst ratings from 12 analysts

Protagonist Therapeutics Inc has a share price target of US$ 108, revenue growth forecast of 859.4%, and profit growth estimate of 254.8% for FY26, based on top 12 analyst calls.